Subscribe
olivier-le-moal-shutterstock-inc-china-
ithinksky / iStockphoto.com
2 August 2017Asia-Pacific

China launches life sciences IP centre

China has launched an IP rights protection centre aimed at providing protection for the biopharmaceutical and high-end manufacturing industries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
China to slash tax for generic makers to 15%
9 April 2018   China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Asia-Pacific
China to slash tax for generic makers to 15%
9 April 2018   China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics.

More on this story

Asia-Pacific
China to slash tax for generic makers to 15%
9 April 2018   China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics.

More features

Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case